Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Aug 10, 2017 9:54pm

130 Views

Post# 26569200

RE:RE:RE:RE:Shortie is capping the Ask

Hi macman1519;

Your statement is not right at all. You won't lose 90% of the market cap by doing a 1:10 reverse split. The market cap remains the same and is simply divided by the new current share count. The same goes for a forward split. If we had a 2:1 forward split, the new share count would just cut the share price in half as the share count had doubled. Any buyout offer would be based on the market cap and then divided by whatever the diluted total share count is at that time.

Thanks;

made2last

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario